Literature DB >> 3889033

Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin.

L Chiovato, P Vitti, A Lombardi, L D Kohn, A Pinchera.   

Abstract

The thyroid microsomal antigen, commonly implicated in thyroid autoimmune diseases, is not confined to cytoplasm, but is also present on the surface of human thyroid cells in primary culture. In this study, a strain of differentiated rat thyroid cells (FRTL5) grown in continuous culture was used to investigate the relationship between functional status of the thyroid cell and expression of microsomal antigen on its surface. Sera from eight patients with Hashimoto's thyroiditis, one with idiopathic hypothyroidism, and three with hyperthyroid Graves' disease were selected for the presence of microsomal antibody, but undetectable thyroglobulin antibody. One additional serum sample from a patient with Graves' disease, which was negative for both thyroid antibodies was used. Sera from eight normal subjects were used as controls. Indirect immunofluorescence was applied to FRTL5 cells that were viable or fixed with acetone in order to expose intracellular antigens. When FRTL5 cells were cultured in Coon's medium containing TSH (300 microU/ml), positive indirect immunofluorescence surface staining was observed with sera containing microsomal antibody, but not with control sera or with the Graves' serum negative for microsomal antibody. A rough correlation was found between the intensity of the surface fluorescence and microsomal antibody titer. After acetone treatment, microsomal antibody-positive sera produced typical cytoplasmic staining. When FRTL5 cells were cultured in the absence of TSH, disappearance of the surface fluorescence and reduction of the cytoplasmic microsomal antigen occurred. Readdition of TSH progressively restored both the surface and cytoplasmic microsomal antigen. The present data indicate that the thyroid microsomal antigen is represented on the surface of FRTL5 cells, and its expression is modulated by TSH.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889033     DOI: 10.1210/jcem-61-1-12

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.

Authors:  L Chiovato; P Vitti; A Lombardi; G Lopez; F Santini; E Macchia; G F Fenzi; C Mammoli; S Battiato; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

3.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.

Authors:  J H Romaldini; M C Werner; H F Rodrigues; V L Teixeira; R S Werner; C S Farah; N Bromberg
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

5.  Unusual association of thyroiditis, Addison's disease, ovarian failure and celiac disease in a young woman.

Authors:  R Valentino; S Savastano; A P Tommaselli; M Dorato; M T Scarpitta; M Gigante; G Lombardi; R Troncone
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

6.  Characterization of monoclonal antibodies directed towards the microsomal/microvillar thyroid autoantigen recognized by Hashimoto autoantibodies.

Authors:  J P Banga; R Mirakian; L Hammond; G Pryce; S Bidey; F Bottazzo; A P Weetman; A M McGregor; I M Roitt
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

7.  L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis.

Authors:  L Chiovato; C Marcocci; S Mariotti; A Mori; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

8.  Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies.

Authors:  L Portmann; F W Fitch; W Havran; N Hamada; W A Franklin; L J DeGroot
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.

Authors:  Yun Mi Choi; Mi Kyung Kwak; Sang Mo Hong; Eun Gyoung Hong
Journal:  Endocrinol Metab (Seoul)       Date:  2019-09

10.  Vitamin D Status and Thyroid Autoantibodies in Autoimmune Thyroiditis.

Authors:  Viktoria F Koehler; Natalie Filmann; W Alexander Mann
Journal:  Horm Metab Res       Date:  2019-11-25       Impact factor: 2.936

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.